Multivariate analysis of the association of acid and duodeno-gastro- oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus

Gut

Volumn 57, Issue 8, 2008, Pages 1056-1064

  Koek, G H ^a   Sifrim, D ^a   Lerut, T ^a   Janssens, J ^a   Tack, J ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACID ASPIRATION; ARTICLE; BARRETT ESOPHAGUS; BODY MASS; DEMOGRAPHY; DISEASE SEVERITY; ENDOSCOPY; ESOPHAGITIS; ESOPHAGUS MANOMETRY; FEMALE; GASTROESOPHAGEAL REFLUX; HIATUS HERNIA; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; BARRETT ESOPHAGUS; BODY MASS INDEX; ESOPHAGITIS, PEPTIC; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HERNIA, HIATAL; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; MONITORING, AMBULATORY; MULTIVARIATE ANALYSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 48249124148     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2006.119206     Document Type: Article

References (56)

1. Jones R, Galmiche JP. Review: what do we mean by GERD? - definition and diagnosis. Aliment Pharmacol Ther 2005;(Suppl 1):2-10.
2. Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Guf 2005;54:1492-9.
3. Tack J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;(Suppl 1):48-54.
4. Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-31.
5. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology 1996;111:1192-9.
6. Koek GH, Vos R, Sifrim D, et al. Mechanisms underlying duodeno-gastric reflux in man. Neurogastroenterol Motil 2005;17:191-9.
7. Kivilaakso E, Fromm D, Silen W. Effect of bile salts and related compounds on isolated esophageal mucosa. Surgery 1980;87:280-5.
8. Goldberg HI, Dodds WJ, Gee S, et al. Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969;56:223-30.
9. Salo JA, Lehto VP, Kivilaakso E. Morphological alterations in experimental esophagitis. Light microscopic and scanning and transmission electron microscopic study. Dig Dis Sci 1983;28:440-8.
10. Salo JA, Kivilaakso E. Role of bile salts and trypsin in the pathogenesis of experimental alkaline esophagitis. Surgery 1983;93:525-32.
11. Johnsson F, Joelsson B, Floren CH, et al. Bile salts in the esophagus of patients with esophagitis. Scand J Gastroenterol 1988;23:712-6.
12. Kauer WK, Peters JH, DeMeester TR, et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. Surgery 1997;122:874-81.
13. Stein HJ, Feussner H, Kauer W, et al. Alkaline gastroesophageal reflux: assessment by ambulatory esophageal aspiration and pH monitoring. Am J Surg 1994;167:163-8.
14. Vaezi MF, Lacamera RG, Richter JE. Validation studies of Bilitec 2000: an ambulatory duodenogastric reflux monitoring system. Am J Physiol 1994;267:G1050-7.
15. Byrne JP, Romagnoli R, Bechi P, et al. Duodenogastric reflux of bile in health: the normal range. Physiol Meas 1999;20:149-58.
16. Stipa F, Stein HJ, Feussner H, et al. Assessment of non-acid esophageal reflux: comparison between long-term reflux aspiration test and fiberoptic bilirubin monitoring. Dis Esophagus 1997;10:24-8.
17. Orlando RC, Bozymski EM. Heartburn in pernicious anemia - a conseguence of bile reflux. N Engl J Med 1973;289:522-3.
18. Matikainen M, Laatikainen T, Kalima T, et al. Bile acid composition and esophagitis after total gastrectomy. Am J Surg 1982;143:196-8.
19. Tack J, Bisschops R, Sifrim D, et al. Dietary restrictions during ambulatory monitoring of duodeno-gastro-esophageal reflux. Dig Dis Sci 2003;48:1213-20.
20. Marshall RE, Anggiansah A. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1996;83:425-6.
21. Kauer WK, Peters JH, DeMeester TR, et al. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg 1995;222:525-31; discussion 531-3.
22. Caldwell MT, Lawlor P, Byrne PJ, et al. Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg 1995;82:657-60.
23. Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett's esophagus. Gastroenterology 1994;107:747-54.
24. Vaezi MF, Richter JE. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus. Surgery 1995;117:699-704.
25. Cuomo R, Koek G, Sifrim D, et al. Analysis of ambulatory duodenogastroesophageal reflux monitoring. Dig Dis Sci 2000;45:2463-9.
26. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-80.
27. Tack J, Koek G, Demedts I, et al. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both? Am J Gastroenterol 2004;99:981-8.
28. Johnsson F, Joelsson B, Gudmundsson K. Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol 1987;22:71-8.
29. Venables T, Newland RD, Patel AC, et al. Maintenance treatment for gastroesophageal reflux disease. A placebo-controlled evaluation of 10 milligrams omeprazole once daily in general practice. Scand J Gastroenterol 1997;32:627-32.
30. Galmiche JP, Barthelemy P, Hamelin B. Treating the symptoms of gastrooesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther 1997;11:765-73.
31. Carlsson R, Dent J, Watts R, et al. Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. Eur J Gastroenterol Hepatol 1998;10:119-124.
32. Cadiot G, Bruhat A, Rigaud D, et al. Multivariate analysis of pathophysiological factors in reflux oesophagitis. Guf 1997;40:167-74.
33. Wilson LJ, Ma W, Hirschowitz BI. Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol 1999;94:2840-4.
34. Chung RS, Magri J, DenBesten L. Hydrogen ion transport in the rabbit esophagus. Am J Physiol 1975;229:496-500.
35. Chung RS, Johnson GM, Denbesten L. Effect of sodium taurocholate and ethanol on hydrogen ion absorption in rabbit esophagus. Am J Dig Dis 1977;22:582-8.
36. Safaie-Shirazi S. Effect of pepsin on ionic permeability of canine esophageal mucosa. J Surg Bes 1977;22:5-8.
37. Salo J, Kivilaakso E. Role of luminal H+ in the pathogenesis of experimental esophagitis. Surgery 1982;92:61-8.
38. Goldstein JL, Schlesinger PK, Mozwecz HL, et al. Esophageal mucosal resistance. A factor in esophagitis. Gastroenterol Clin North Am 1990;19:565-86.
39. Bateson MC, Hopwood D, Milne G, et al. Oesophageal epithelial ultrastructure after incubation with gastrointestinal fluids and their components. J Pathol 1981;133:33-51.
40. Lillemoe KD, Kidder GW, Harmon JW, et al. Tauroursodeoxycholic acid is less damaging than taurochenodeoxycholic acid to the gastric and esophageal mucosa. Dig Dis Sci 1983;28:359-64.
41. Harmon JW, Johnson LF, Maydonovitch CL. Effects of acid and bile salts on the rabbit esophageal mucosa. Dig Dis Sci 1981;26:65-72.
42. Lillemoe KD, Johnson LF, Harmon JW. Role of the components of the gastroduodenal contents in experimental acid esophagitis. Surgery 1982;92:276-84.
43. Lillemoe KD, Gadacz TR, Harmon JW. Bile absorption occurs during disruption of the esophageal mucosal barrier. J Surg Res 1983;35:57-62.
44. Palmer ED. Subacute erosive peptic esophagitis associated with achlorhydria. N Engl J Med 1960;262:927 929.
45. Wilmer A, Tack J, Frans E, et al. Duodenogastroesophageal reflux and esophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999;116:1293-9.
46. Campos GM, DeMeester SR, Peters JH, et al. Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg 2001;136:1267-73.
47. Caygill CP, Johnston DA, Lopez M, et al. Lifestyle factors and Barrett's esophagus. Am J Gastroenterol 2002;97:1328-31.
48. Gray MR, Donnelly RJ, Kingsnorth AN. The role of smoking and alcohol in metaplasia and cancer risk in Barrett's columnar lined oesophagus. Gut 1993;34:727-31.
49. Levi F, Ollyo JB, La Vecchia C, et al. The consumption of tobacco, alcohol and the risk of adenocarcinoma in Barrett's oesophagus. Int J Cancer 1990;45:852-4.
50. Kaur BS, Ouatu-Lascar R, Omary MB, et al. Bile salts induce or blunt cell proliferation in Barrett's esophagus in an acid-dependent fashion. Am J Physiol Gastrointest Liver Physiol 2000;278:G1000-9.
51. Tselepis C, Morris CD, Wakelin D, et al. Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut 2003;52:174-80.
52. Kandil HM, Tanner G, Smalley W, et al. Cyclooxygenase-2 expression in Barrett's esophagus. Dig Dis Sci 2001;46:785-9.
53. Kaur BS, Triadafilopoulos G. Acid- and bile-induced PGE (2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. Am J Physiol Gastrointest Liver Physiol 2002;283:G327- 34.
54. Vieth M, Masoud B, Meining A, et al. Helicobacter pylori infection: protection against Barrett's mucosa and neoplasia? Digestion 2000;62:225-31.
55. Oberg S, Peters JH, Nigra JJ, et al. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 1999;134:722-6.
56. O'Connor HJ, Cunnane K. Helicobacter pylori and gastro-oesophageal reflux disease-a prospective study. Ir J Med Sci 1994;163:369-73.